PP
XBI icon

Patten & Patten’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Patten & Patten’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$699K Sell
5,475
-351
-6% -$43.8K 0.04% 215
2025
Q4 		$710K Hold
5,826
– – 0.04% 213
2025
Q3 		$584K Buy
5,826
+165
+3% +$14.9K 0.03% 232
2025
Q2 		$469K Sell
5,661
-895
-14% -$71.4K 0.03% 235
2025
Q1 		$532K Buy
6,556
+401
+7% +$35.8K 0.04% 220
2024
Q4 		$554K Sell
6,155
-390
-6% -$37.8K 0.04% 209
2024
Q3 		$647K Sell
6,545
-175
-3% -$17.2K 0.04% 201
2024
Q2 		$623K Buy
6,720
+375
+6% +$33.6K 0.04% 197
2024
Q1 		$602K Sell
6,345
-365
-5% -$33.9K 0.04% 204
2023
Q4 		$599K Sell
6,710
-495
-7% -$36.8K 0.05% 181
2023
Q3 		$526K Sell
7,205
-500
-6% -$39.9K 0.05% 192
2023
Q2 		$641K Sell
7,705
-10
-0.1% -$836 0.05% 179
2023
Q1 		$588K Sell
7,715
-235
-3% -$19.5K 0.05% 182
2022
Q4 		$660K Sell
7,950
-440
-5% -$35.6K 0.06% 174
2022
Q3 		$665K Buy
8,390
+25
+0.3% +$2.11K 0.06% 170
2022
Q2 		$621K Sell
8,365
-485
-5% -$36.4K 0.05% 182
2022
Q1 		$795K Sell
8,850
-310
-3% -$28.6K 0.06% 172
2021
Q4 		$1.03M Sell
9,160
-600
-6% -$72.4K 0.07% 152
2021
Q3 		$1.23M Buy
9,760
+10
+0.1% +$1.29K 0.09% 132
2021
Q2 		$1.32M Sell
9,750
-195
-2% -$25.6K 0.1% 128
2021
Q1 		$1.35M Sell
9,945
-45
-0.5% -$6.74K 0.11% 121
2020
Q4 		$1.41M Buy
9,990
+75
+0.8% +$9.61K 0.12% 114
2020
Q3 		$1.1M Buy
9,915
+2,420
+32% +$271K 0.11% 123
2020
Q2 		$839K Sell
7,495
-165
-2% -$16.3K 0.09% 139
2020
Q1 		$593K Buy
7,660
+5
+0.1% +$443 0.08% 152
2019
Q4 		$728K Hold
7,655
– – 0.07% 159
2019
Q3 		$584K Sell
7,655
-1,420
-16% -$118K 0.06% 163
2019
Q2 		$796K Sell
9,075
-680
-7% -$58K 0.09% 147
2019
Q1 		$883K Sell
9,755
-235
-2% -$20K 0.1% 136
2018
Q4 		$717K Buy
9,990
+110
+1% +$8.86K 0.09% 144
2018
Q3 		$947K Buy
9,880
+1,335
+16% +$129K 0.09% 138
2018
Q2 		$813K Buy
8,545
+1,490
+21% +$137K 0.08% 148
2018
Q1 		$619K Buy
7,055
+275
+4% +$25.1K 0.06% 163
2017
Q4 		$575K Sell
6,780
-150
-2% -$12.6K 0.06% 170
2017
Q3 		$600K Buy
6,930
+700
+11% +$56.1K 0.06% 170
2017
Q2 		$481K Buy
6,230
+270
+5% +$19.1K 0.05% 183
2017
Q1 		$413K Sell
5,960
-5
-0.1% -$336 0.05% 187
2016
Q4 		$353K Sell
5,965
-425
-7% -$26.2K 0.04% 177
2016
Q3 		$424K Buy
6,390
+25
+0.4% +$1.55K 0.05% 162
2016
Q2 		$344K Buy
6,365
+185
+3% +$10.1K 0.05% 169
2016
Q1 		$319K Hold
6,180
– – 0.05% 174
2015
Q4 		$434K Sell
6,180
-4,500
-42% -$307K 0.06% 161
2015
Q3 		$665K Sell
10,680
-6,255
-37% -$493K 0.1% 127
2015
Q2 		$1.42M Buy
16,935
+615
+4% +$47.8K 0.21% 97
2015
Q1 		$1.23M Buy
16,320
+180
+1% +$12.6K 0.18% 104
2014
Q4 		$1M Buy
16,140
+5,010
+45% +$286K 0.15% 114
2014
Q3 		$579K Buy
11,130
+1,470
+15% +$75K 0.09% 142
2014
Q2 		$496K Sell
9,660
-825
-8% -$37.2K 0.08% 148
2014
Q1 		$498K Sell
10,485
-22,875
-69% -$1.17M 0.07% 186
2013
Q4 		$1.45M Sell
33,360
-885
-3% -$36.6K 0.2% 103
2013
Q3 		$1.47M Buy
34,245
+1,020
+3% +$41.3K 0.23% 91
2013
Q2 		$1.16M Buy
+33,225
New +$1.17M 0.19% 108

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Patten & Patten's XBI Position: Q1 2026 in Review

Patten & Patten reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 6% in Q1 2026, selling an estimated $43.8K and leaving 5,475 shares worth $699K. The position accounts for 0.04% of the portfolio, ranked #215.

Patten & Patten first reported a position in XBI in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.47M in Q3 2013. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Patten & Patten held 5,475 shares of State Street SPDR S&P Biotech ETF worth $699K as of Q1 2026.
  • Patten & Patten sold 351 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $43.8K.
  • State Street SPDR S&P Biotech ETF made up 0.04% of Patten & Patten's portfolio in Q1 2026, its #215 holding.
  • Patten & Patten first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 52 quarters since.
  • Patten & Patten's State Street SPDR S&P Biotech ETF position peaked at $1.47M in Q3 2013.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Patten & Patten's 13F filing for Q1 2026, filed 1 May 2026.